Episode 87. This is a conversation I've been anticipating for a while now, but likely wouldn't have had even as recently as a few years ago. To be honest, I was scared to do it. As a professional who believes that no one should feel pressure to lose weight, I don't want to have anyone see that I have a podcast about this topic and believe I think they should take these meds or be trying to shrink their body. But you know why I was most nervous to have the episode? Because I didn't want my professional colleagues to judge or think less of me. I'm putting this episode out into the world because I believe individuals should not feel shame if they decide to make weight loss medications part of their journey. I also strongly believe that our professional world is split into many different "us versus them" camps, and it's incredibly counterproductive. We all have the same goals, to make our clients or patients feel good and well. What to Expect in this Interview In this interview, we cover: * Some of the history of weight loss medication options (and why I likely wouldn't have had an episode like this a few years ago) * A brief overview of weight loss medication options available (including a brief overview of non-GLP-1 agonist medications such as Contrave and Orlistat) * An overview of the mechanism of action for GLP-1 agonist medications (I get questions about these medications almost weekly lately) * Brief review of the risks and benefits from medical and psychological standpoints Ready to Break the Emotional Eating Cycle for Good? Ready to stop avoiding and break the binge eating cycle for good? The first step is to tune in to your body with curiosity and awareness. Grab the free step-by-step guide today! Grab my free guide to disrupt the cycle of emotional eating today! Medications We Covered Dr. Egan gave a brief overview of some of the pros and cons of non-GLP-1 agonist options: * Contrave (combination of bupropion and naltrexone) * Qsymia (phentermine and Topiramate) * Orlistat * Plenity (newer medication, only very short-term studies) GLP-1 Agonist Medications * Saxenda (liraglutide) * Wegovy (semaglutide) * Mounjaro (tirzepatide) - currently only approved for people with a diagnosis of diabetes. This medication is a GLP-1 and GIP receptor agonist. Who is Dr. Celia Egan? Dr. Egan joined True Women’s Health® over a year ago after practicing Obesity Medicine and Internal Medicine at Spectrum Health Medical Group.  At True, she focuses on what she loves including extensive patient care in medical weight management and providing evidence-based wellness expertise to women in a primary care setting. Born and raised in West Michigan, Dr. Egan completed her undergraduate studies at the University of Michigan. After earning her MD from New York Medical College, she completed her internship and residency in Internal Medicine at Weill Cornell Medical Center- New York-Presbyterian Hospital in New York, NY.